Your browser doesn't support javascript.
loading
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors.
Sottile, Rosa; Pangigadde, Pradeepa N; Tan, Thomas; Anichini, Andrea; Sabbatino, Francesco; Trecroci, Francesca; Favoino, Elvira; Orgiano, Laura; Roberts, James; Ferrone, Soldano; Kärre, Klas; Colucci, Francesco; Carbone, Ennio.
Afiliação
  • Sottile R; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
  • Pangigadde PN; University Magna Graecia of Catanzaro, Catanzaro, Italy.
  • Tan T; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
  • Anichini A; University Magna Graecia of Catanzaro, Catanzaro, Italy.
  • Sabbatino F; Department of Obstetrics and Gynaecology, University of Cambridge School of Clinical Medicine, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
  • Trecroci F; Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Favoino E; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Orgiano L; University Magna Graecia of Catanzaro, Catanzaro, Italy.
  • Roberts J; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Ferrone S; Department of Obstetrics and Gynaecology, University of Cambridge School of Clinical Medicine, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
  • Kärre K; Department of Obstetrics and Gynaecology, University of Cambridge School of Clinical Medicine, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
  • Colucci F; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Carbone E; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
Eur J Immunol ; 46(2): 409-19, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26564811
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Antígenos HLA-A / Imunoterapia Adotiva / Interleucina-2 / Melanoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Immunol Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Antígenos HLA-A / Imunoterapia Adotiva / Interleucina-2 / Melanoma Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Immunol Ano de publicação: 2016 Tipo de documento: Article